RPL10P5

Across TCGA pan-cancer cohorts, RPL10P5 RNA is linked to patient survival in 26 of 34 cancer types, making it the most broadly survival-associated RPL10P5 data layer.

The strongest signal is observed in kidney chromophobe (KICH), where higher RPL10P5 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPL10P5 expression acts as an unfavorable survival marker, although some lineages such as READ and CESC show a favorable association.

KICH, READ, and CESC are the cancer types where RPL10P5 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	DFS	Median	II,III,IV	0.645	0.963	.001	49	view →
READ	DFS	Tertile	All	0.969	0.685	.006	21	view →
CESC	OS	Tertile	II,III,IV	0.700	0.368	.013	20	view →
CHOL	OS	Tertile	IV	0.024	0.732	.014	18	view →
UCS	DFS	Median	IV	0.850	0.475	.023	18	view →
ACC	OS	Tertile	All	0.663	1.000	.003	17	view →
SARC	OS	Median	All	0.773	0.932	<.001	16	view →
SKCM	DFS	Median	IV	0.662	0.190	.006	15	view →
STAD	OS	Median	II,III,IV	0.609	0.738	.008	15	view →
GBM	DFS	Quartile	All	0.329	0.206	.014	14	view →
HNSC	DFS	Tertile	III,IV	0.551	0.322	.010	14	view →
THCA	DFS	Tertile	All	0.949	0.868	.006	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 26 lineages.

RPL10P5–KICH (DFS)

Open the KICH breakdown →